Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 2/20 | 0.64 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CCR1 | P32246 | 2/20 | 0.57 |
| ▸ | CCR5 | P51681 | 2/20 | 0.57 |
| ▸ | CCR8 | P51685 | 2/20 | 0.57 |
| ▸ | PARP1 | P09874 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | SLC40A1 | Q9NP59 | 6/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27991417 | 0.84 | PSMD14 (0.57) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL22326602 | 0.81 | PSMD14 (0.41) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL3051052 | 0.81 | PSMD14 (0.41) | PSMD14COPS5KDM4EPARP1SLC40A1 | |
| SCHEMBL8547571 | 0.81 | PSMD14 (0.41) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL13587039 | 0.79 | CCR1 (0.58) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL23717257 | 0.78 | PSMD14 (0.42) | PSMD14COPS5KDM4EPARP1NR1H2 | |
| SCHEMBL24987024 | 0.78 | PARP1 (0.55) | PSMD14COPS5KDM4EPARP1CYP1A2 | |
| SCHEMBL3718782 | 0.78 | KDM4E (0.62) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL3067414 | 0.78 | PSMD14 (1.00) | PSMD14COPS5KDM4ECCR1CCR5 | |
| SCHEMBL13301166 | 0.77 | PSMD14 (0.62) | PSMD14COPS5KDM4ECCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | GABBR1, DPM1, CYP51A1 | PSMD14 2765/4885COPS5 773/4885KDM4E 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.